Harvard Apparatus Regenerative Technology

  • HART Building

Investor Relations

About Us

HART was incorporated on May 3, 2012 by Harvard Bioscience to provide a clinical-stage regenerative medicine company developing life-saving medical devices. Harvard Bioscience has been designing and manufacturing devices for life science researchers for over 100 years. HART was first established in 2007 to explore the regenerative medicine market and determine if the company's expertise and commitment to leading edge technology could be applied to treating unmet critical medical needs. HART has grown to become the recognized leader in providing scaffolds, bioreactors and other tools for synthetic tracheas.

Stock Information

Featured Financial Releases